Ionpath Overview
- Year Founded
-
2014
- Status
-
Out of Business
- Employees
-
34
- Latest Deal Type
-
Liquidation
Ionpath General Information
Description
Developer of an ion beam imaging technology designed to offer tissue imaging and analysis to accelerate discovery and improve human health. The company's technology offers a deep understanding of the tissue microenvironment with highly multiplexed quantitative single-cell analysis, enabling healthcare providers to provide a diagnosis of cancer through proper actionable insights.
Contact Information
Website
www.ionpath.comCorporate Office
- 960 O'Brien Drive
- Menlo Park, CA 94025
- United States
Corporate Office
- 960 O'Brien Drive
- Menlo Park, CA 94025
- United States
Ionpath Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 6. Bankruptcy: Liquidation | 27-May-2025 | Completed | Bankruptcy: Liquidation | |||
| 5. Later Stage VC (Series C) | 11-May-2022 | Completed | Generating Revenue | |||
| 4. Later Stage VC (Series B) | 24-Sep-2020 | Completed | Generating Revenue | |||
| 3. Debt - PPP | 14-Apr-2020 | Completed | Generating Revenue | |||
| 2. Later Stage VC (Series A) | 01-Jul-2019 | $30.4M | $33M | Completed | Generating Revenue | |
| 1. Early Stage VC (Series A1) | $2.6M | $2.6M | Completed | Startup |
Ionpath Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series NV C | ||||||||
| Series Voting C | ||||||||
| Series B | ||||||||
| Series A-1 | 1,582,839 | $0.000100 | $1.65 | $1.65 | 1x | $1.13 | 1.62% | |
| Series A | 5,006,300 | $0.000100 | $3.58 | $3.58 | 1x | $1.73 | 7.22% |
Ionpath Comparisons
Industry
Financing
Details
Ionpath Competitors (32)
One of Ionpath’s 32 competitors is Oxford Nanopore Technologies, a Formerly VC-backed company based in Oxford, United Kingdom.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Oxford Nanopore Technologies | Formerly VC-backed | Oxford, United Kingdom | ||||
| Ultivue | Formerly VC-backed | Cambridge, MA | ||||
| Foundation Medicine | Formerly VC-backed | Boston, MA | ||||
| Ozette | Venture Capital-Backed | Seattle, WA | ||||
| Element Biosciences | Venture Capital-Backed | San Diego, CA |
Ionpath Patents
Ionpath Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| EP-3906414-A1 | Compositions and reagents for ion beam imaging | Inactive | 03-Jan-2019 | ||
| JP-2022517193-A | Compositions and reagents for ion beam imaging | Pending | 03-Jan-2019 | ||
| WO-2020142664-A1 | Compositions and reagents for ion beam imaging | Inactive | 03-Jan-2019 | ||
| JP-2021516339-A | Source / detector synchronization in multiplexed secondary ion mass spectrometry | Active | 28-Feb-2018 | ||
| EP-3759498-A1 | Source-detector synchronization in multiplexed secondary ion mass spectrometry | Active | 28-Feb-2018 | H01J49/403 |
Ionpath Signals
Ionpath FAQs
-
When was Ionpath founded?
Ionpath was founded in 2014.
-
Where is Ionpath headquartered?
Ionpath is headquartered in Menlo Park, CA.
-
What is the size of Ionpath?
Ionpath has 34 total employees.
-
What industry is Ionpath in?
Ionpath’s primary industry is Diagnostic Equipment.
-
Is Ionpath a private or public company?
Ionpath is a Private company.
-
What is Ionpath’s current revenue?
The current revenue for Ionpath is .
-
How much funding has Ionpath raised over time?
Ionpath has raised $86M.
-
Who are Ionpath’s competitors?
Oxford Nanopore Technologies, Ultivue, Foundation Medicine, Ozette, and Element Biosciences are some of the 32 competitors of Ionpath.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process